IL6 and rheumatoid arthritis: Several studies showed that MI192 has dose-dependent inhibition for interleukin-6 (IL-6), and peripheral blood mononuclear cells (PBMC) in rheumatoid arthritis (RA) patients but not in healthy control [45,48,49].